EdgeMarket › What Board Of Trustees Of The Leland Stanford Junior University reported owning

What Board Of Trustees Of The Leland Stanford Junior University reported owning

As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.

Reported value

848.7M

Positions

22

Quarter

2026-03-31

Shown below

22
largest by value
holdingvalue% of booksharesprice1y
EEM
iShares MSCI Emerging Markets ETF
513.2M60.5%9.0M67.12+34.9%
GOOGL
Alphabet Inc.
113.4M13.4%394.4K344.82+73.0%
EWJ
iShares MSCI Japan ETF
82.0M9.7%971.3K95.18+19.5%
EFA
iShares MSCI EAFE ETF
48.9M5.8%503.6K108.24+17.1%
SPY
SPDR S&P 500 ETF TRUST
47.5M5.6%73.1K765.72+20.0%
KOD
Kodiak Sciences Inc.
26.4M3.1%691.8K38.33+303.5%
MPLT
MapLight Therapeutics, Inc.
4.1M0.5%199.2K11.21
ANNX
Annexon, Inc.
2.7M0.3%482.6K5.07+136.9%
BSM
Black Stone Minerals, L.P.
2.2M0.3%147.9K14.89+23.6%
WLTH
WEALTHFRONT CORP
1.9M0.2%208.5K9.22+8.5%
KRP
Kimbell Royalty Partners, LP
1.6M0.2%111.6K15.40+13.7%
NAVN
Navan, Inc.
1.5M0.2%110.6K29.16
VNOM
Viper Energy, Inc.
1.2M0.1%25.0K45.27+21.6%
CHYM
Chime Financial, Inc.
788.7K0.1%42.1K32.78+23.4%
MATX
Matson, Inc.
442.6K0.1%2.7K222.80+119.1%
LIFE
Ethos Technologies Inc.
356.8K0.0%31.9K34.16+2239.7%
MRLN
Merlin, Inc.
240.1K0.0%32.7K3.28-68.4%
unmapped CUSIP 097702203145.3K0.0%36.0K
CARL
CARLSMED, INC.
113.3K0.0%12.5K16.05+33.0%
AMTX
AEMETIS, INC
80.7K0.0%25.3K2.07-15.2%
HTCR
HeartCore Enterprises, Inc.
22.4K0.0%100.0K2.66-74.1%
SKIN
SkinHealth Systems Inc.
8.9K0.0%10.0K0.65-69.2%

A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →

The whole archive is one click away.

Screener, filings, insider flow, backtests and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →